The McGill consensus statement on overdentures. Mandibular two-implant overdentures as first choice standard of care for edentulous patients. Montreal, Quebec …
JS Feine, GE Carlsson, MA Awad… - … journal of oral & …, 2002 - pubmed.ncbi.nlm.nih.gov
… JS Feine, GE Carlsson, MA Awad, A Chehade, WJ Duncan, S Gizani, T Head, JP Lund,
M MacEntee, R Mericske-Stern, P Mojon, J Morais, I Naert, AGT Payne, J Penrod, GT Stoker …
M MacEntee, R Mericske-Stern, P Mojon, J Morais, I Naert, AGT Payne, J Penrod, GT Stoker …
Recent advances in indoor localization: A survey on theoretical approaches and applications
A Yassin, Y Nasser, M Awad, A Al-Dubai… - … Surveys & Tutorials, 2016 - ieeexplore.ieee.org
… The accuracies in order of 0.2 m are possible when utilizing commodity hardware. Additionally,
the maximum error achieved in the worst case scenario can be decreased to reach 1.6 m…
the maximum error achieved in the worst case scenario can be decreased to reach 1.6 m…
The McGill consensus statement on overdentures. Mandibular two-implant overdentures as first choice standard of care for edentulous patients
JS Feine, GE Carlsson, MA Awad… - …, 2002 - pubmed.ncbi.nlm.nih.gov
… JS Feine, GE Carlsson, MA Awad, A Chehade, WJ Duncan, S Gizani, T Head, G
Heydecke, JP Lund, M MacEntee, R Mericske-Stern, P Mojon, JA Morais, I Naert, AGT Payne …
Heydecke, JP Lund, M MacEntee, R Mericske-Stern, P Mojon, JA Morais, I Naert, AGT Payne …
[HTML][HTML] Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer
…, M Provencio, T Mitsudomi, MM Awad… - … England Journal of …, 2022 - Mass Medical Soc
Background Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery
alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-…
alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-…
Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases
Y Murayama, T Malisch, G Guglielmi, ME Mawad… - Journal of …, 1997 - thejns.org
… Awad, et al.,3 in a detailed evaluation of the incidence of vasospasm caused by SAH in spite
of … Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. …
of … Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. …
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label …
…, JCH Yang, M Gubens, LV Sequist, MM Awad… - The lancet …, 2016 - thelancet.com
Background Limited evidence exists to show that adding a third agent to platinum-doublet
chemotherapy improves efficacy in the first-line advanced non-small-cell lung cancer (NSCLC…
chemotherapy improves efficacy in the first-line advanced non-small-cell lung cancer (NSCLC…
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
…, DM Greenawalt, MD Hellmann, MM Awad… - Cancer discovery, 2018 - AACR
KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously
reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups of …
reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups of …
[HTML][HTML] Support vector regression
M Awad, R Khanna, M Awad, R Khanna - Efficient learning machines …, 2015 - Springer
… Here, M is the order of the polynomial used to approximate a function. As the magnitude of
the vector w increases, a greater number of w i are nonzero, resulting in higher-order solutions…
the vector w increases, a greater number of w i are nonzero, resulting in higher-order solutions…
[HTML][HTML] Acquired Resistance to KRASG12C Inhibition in Cancer
MM Awad, S Liu, II Rybkin, KC Arbour… - … England Journal of …, 2021 - Mass Medical Soc
Background Clinical trials of the KRAS inhibitors adagrasib and sotorasib have shown
promising activity in cancers harboring KRAS glycine-to-cysteine amino acid substitutions at …
promising activity in cancers harboring KRAS glycine-to-cysteine amino acid substitutions at …
Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection
ME Mawad, S Cekirge, E Ciceri, I Saatci - Journal of neurosurgery, 2002 - thejns.org
Object. The aim of this study was to test the feasibility, safety, and efficacy of a new endovascular
method for the treatment of giant intracranial aneurysms. This new method consists of …
method for the treatment of giant intracranial aneurysms. This new method consists of …